MusclePharm’s liquidating plan became effective on March 6, 2025, transferring estate assets and litigation claims to Nathan F. Smith’s liquidating trust, as established by the effective-date notice Dkt. 1602. The path to creditor distributions centers on recoveries and claims resolution: the trustee’s June 4, 2025 motion Dkt. 1693 reported insufficient funds to pay pending administrative and professional fee claims in full while he pursued third-party recoveries.

MusclePharm’s liquidating plan became effective on March 6, 2025, transferring estate assets and litigation claims to Nathan F. Smith’s liquidating trust, as established by the effective-date notice Dkt. 1602. The path to creditor distributions centers on recoveries and claims resolution: the trustee’s June 4, 2025 motion Dkt. 1693 reported insufficient funds to pay pending administrative and professional fee claims in full while he pursued third-party recoveries.